A preparative method of chronic experiment autoimmune encephalomyelitis

Journal of Central South University (Medical Sciences)

Volumn 33, Issue 8, 2008, Pages 663-668

  Yan, Jin Jin ^a   Huang, Guo Xiang ^a   Xiao, Bo ^a   Yang, Huan ^a   Wu, Zhi Guo ^a   Zhou, Wen Bin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Animal model; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

FREUND ADJUVANT; GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35 55); MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; FEMALE; MOUSE; RANDOMIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; GLYCOPROTEINS; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; RANDOM ALLOCATION;

EID: 53649096533     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Linington M B C. Animal models of demyelination[J]. Brain Pathol,2008,6(3):303-311.
2. Slavin A, Ewing C, Liu J, et al. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein[J]. Autoimmunity,1998,28(2):109-120.
3. Trotter J L, Damico C A, Cross A H, et al. HPRT mutant T-cell lines from MS patients recognize myelin proteolipid protein peptides[J]. J Neuro Immunol,1997,75(1-2):95-103.
4. Kerlero de Rosbo N, Milo R, Lees M B, et al. Reactivity to myelin antigens in multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein[J]. J Clin Invest,1993,92(6):2602-2608.
5. Mix E, Ibrahim S, Pahnke J, et al. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process[J]. J Neuroimmunol,2004,151(1-2):158-170.
6. Amiguet P, Gardinier M V, Zanetta J P, et al. Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein[J]. J Neurochem,1992,58(5):1676-1682.
7. Ben-Nun A, Mendel I, Bakimer R, et al. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease[J]. J Neurol,1996,243(4):S14-22.
8. Mendel I, Kerlero N, Rosbo D, et al. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells[J]. Eur J Immunol,1995,25(7):1951-1959.
9. Benson J M, Stuckman S S, Cox K L, et al. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis[J]. J Immunol,1999,162(10):6247-6254.
10. WANG Qiong, GAO Bo-ting, WANG Wei, et al. Pathological changes in mice with experimental autoimmune encephalomyelitis[J]. Stoke and Nervous Disease,2006,13(2):97-102.
11. Dijkhuizen R M, Nicolay K. Magnetic resonance imaging in experimental models of brain disorders[J]. J Cereb Blood Flow Metab,2003,23(12):1383-1402.
12. LI J, Gran B, Zhang G X, et al. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis[J]. J Neurol Sci,2005,232(1-2):3-9.